Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

GRFS - Grifols, S.A. Latest News | Finranks

Home

GRFS

(GRFS)

NMS – Real Time Price. Currency in USD

7.49

-0.13 (-1.71%)

At close: Mar 27, 2026, 4:00 PM EDT

7.64

+0.15 (2.00%)

After-hours: Mar 27, 2026, 6:12 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Grifols approves IPO of its US biopharma business

Grifols approves IPO of its US biopharma business

Healthcare company Grifols ‌said on Tuesday it ⁠has approved a U.S. initial public offering of ‌its ⁠U.S. biopharma business.

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

BARCELONA, Spain, March 17, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today shared proof-of-concept data from its Chronos-PD program, demonstrating that biological changes in individuals with Parkinson's disease (PD) occur more than a decade before clinical diagnosis, with potential future implications for early detection and intervention.

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

TORONTO, March 13, 2026 (GLOBE NEWSWIRE) -- The Ontario and Manitoba Health Coalitions held a press conference this morning to respond to a report from CBC about two patients who died in Winnipeg after having their blood plasma harvested at centres owned by for-profit pharmaceutical corporation Grifols. Another report followed, of a man who is suing , alleging kidney damage from equipment failure while having his plasma harvested at a Grifols centre. The Alberta Friends of Medicare revealed that Grifols has been found non-compliant with serious breaches at their Calgary centre. Inspection reports from Health Canada show that four Grifols centres have been found non-compliant in Calgary , Alberta; St. John , New Brunswick; and Regina and Saskatoon , Saskatchewan.

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

WINNIPEG, Manitoba and TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- What: Spokespeople from the Manitoba Health Coalition and Ontario Health Coalition will respond to the sad news of two deaths of paid “donors” at for-profit plasma collection facilities owned by pharma giant Grifols. The Coalitions have long raised warnings about safety and the ownership and control of the blood system.

Grifols: I'm Very Happy To Add In 2026

Grifols: I'm Very Happy To Add In 2026

Grifols is a global leader in blood plasma, now rated 'BUY' with a €20/share PT and $23/share ADR target. GRFS has delivered €450M in cost savings, 150%+ net profit growth, and FCF exceeding guidance, with leverage down to 4.2x. Despite a BB- rating, improved fundamentals, dividend reinstatement, and forecasted 20–25% annual growth support a strong risk/reward profile.

Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript

Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript

Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript

Grifols doubles net profit in 2025, driven by revenues

Grifols doubles net profit in 2025, driven by revenues

Spanish drugmaker Grifols reported on Thursday a net profit of 402 million euros ($473.96 million) for 2025, more than double what it recorded the previous year, driven by revenues of 7.5 billion euros, up 7% from a year earlier.

Videos

No Data

There is no data to display

Press releases

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

BARCELONA, Spain, March 17, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today shared proof-of-concept data from its Chronos-PD program, demonstrating that biological changes in individuals with Parkinson's disease (PD) occur more than a decade before clinical diagnosis, with potential future implications for early detection and intervention.

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

TORONTO, March 13, 2026 (GLOBE NEWSWIRE) -- The Ontario and Manitoba Health Coalitions held a press conference this morning to respond to a report from CBC about two patients who died in Winnipeg after having their blood plasma harvested at centres owned by for-profit pharmaceutical corporation Grifols. Another report followed, of a man who is suing , alleging kidney damage from equipment failure while having his plasma harvested at a Grifols centre. The Alberta Friends of Medicare revealed that Grifols has been found non-compliant with serious breaches at their Calgary centre. Inspection reports from Health Canada show that four Grifols centres have been found non-compliant in Calgary , Alberta; St. John , New Brunswick; and Regina and Saskatoon , Saskatchewan.

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

WINNIPEG, Manitoba and TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- What: Spokespeople from the Manitoba Health Coalition and Ontario Health Coalition will respond to the sad news of two deaths of paid “donors” at for-profit plasma collection facilities owned by pharma giant Grifols. The Coalitions have long raised warnings about safety and the ownership and control of the blood system.